He Changsheng, Wu Xingjiang, Cao Jianmin, Fan Xinxin, Liu Kai, Liu Baochen
Institute of General Surgery, Nanjing Jinling Hospital, 305 East Zhongshan Road, Nanjing 210002, China.
J Med Case Rep. 2013 May 28;7:140. doi: 10.1186/1752-1947-7-140.
Spontaneous atraumatic true axillary artery aneurysm is a relatively unusual disorder. Although most cases are asymptomatic, complications of axillary artery aneurysms may result in acute vascular insufficiency and neurological deficits. Prompt treatment, therefore, should be employed in the management of this condition. To date, the standard treatment for peripheral aneurysms is still surgical resection with end-to-end anastomosis. However, aneurysmectomy and interposition grafting with autologous or artificial vessels are more invasive and time-consuming. The ideal treatment for axillary artery aneurysm should be relatively noninvasive, safe and free of significant complications, cost-effective, cosmetically acceptable, and incur less absence from usual daily activities. Endovascular stent grafts have also been successfully used to treat these aneurysms. Management of select aneurysms using stent grafts has become more prevalent with the developing endoluminal technology.
We report a case of a spontaneous atraumatic axillary artery aneurysm where the patient was a 48-year-old ethnic Han Chinese woman with a gradually enlarging left axillary pulsatile mass. She was treated with endovascular stent grafts. The postoperative course of the patient was uneventful during the six-month follow-up.
We show that there are significant early advantages with the endovascular management technique versus the conventional operation in the management of axillary artery aneurysm.
自发性非创伤性真性腋动脉瘤是一种相对罕见的疾病。尽管大多数病例无症状，但腋动脉瘤的并发症可能导致急性血管功能不全和神经功能缺损。因此，对此类疾病的治疗应迅速。迄今为止，外周动脉瘤的标准治疗方法仍是手术切除并进行端端吻合。然而，动脉瘤切除术及使用自体或人工血管进行间置移植术更具侵入性且耗时较长。理想的腋动脉瘤治疗方法应相对无创、安全且无重大并发症、具有成本效益、在美观上可接受，并且使患者日常活动的缺勤时间减少。血管内支架移植物也已成功用于治疗此类动脉瘤。随着腔内技术的发展，使用支架移植物治疗特定动脉瘤的方法已变得更为普遍。
我们报告一例自发性非创伤性腋动脉瘤病例，患者为一名48岁的汉族女性，左腋部有一逐渐增大的搏动性肿块。她接受了血管内支架移植物治疗。在六个月的随访期间，患者术后过程平稳。
我们表明，在腋动脉瘤的治疗中，与传统手术相比，血管内治疗技术具有显著的早期优势。
